FZD6 and esophageal cancer: In agreement with this, increased expression of FZD6 has been reported in many cancer types, and correlates with poor prognosis in patients with breast, brain and esophageal cancer (Corda et al. 2017; Huang et al. 2016; Zhang et al. 2019).